抗体引导下的切除术（REGAJ）：卵巢癌患者二次探查手术中的一种诊断程序。
Resection guided by antibodies (REGAJ): a diagnostic procedure during second-look operation in ovarian cancer patients.
作者信息
Jäger W, Feistel H, Paterok E M, Ronay G, Tulusan A H, Wolf F, Lang N
机构信息
Department of Obstetrics and Gynecology, University of Erlangen-Nürnberg, FRG.
出版信息
Br J Cancer Suppl. 1990 Jul;10:18-20.
Abstract
A hand-held probe has been used to localise the 131I-labelled antibody OC125 during second-look operation (SLO) in 22 ovarian cancer patients. In six patients microscopic cancer was detected with the procedure and a further six patients with areas of increased radioactivity during SLO developed recurrent disease within 1-4 months. We suggest examining resection guided by antibodies as a possible means of removing antigen-producing cancerous tissues during surgery.
摘要
在22例卵巢癌患者的二次探查手术（SLO）中，使用手持探头对131I标记的抗体OC125进行定位。在6例患者中，通过该操作检测到微小癌，另有6例在二次探查手术期间放射性增强区域的患者在1 - 4个月内出现复发性疾病。我们建议将抗体引导下的切除术作为手术中切除产生抗原的癌组织的一种可能方法进行研究。
相似文献
1
2
The role of the CA 125 assay in the management of ovarian cancer.CA 125检测在卵巢癌管理中的作用。
Oncology (Williston Park). 1988 Aug;2(8):67-76.
3
[Chemotherapy and surgical procedure in the management of ovarian malignancies. Evaluation of second look operations].[卵巢恶性肿瘤治疗中的化疗与外科手术。二次探查手术的评估]
Gan To Kagaku Ryoho. 1987 May;14(5 Pt 2):1664-70.
4
Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.卵巢癌患者中，在抗体引导下切除肿瘤（REGAJ）后放射性标记的抗CA125单克隆抗体OC125 - F(ab)2片段的分布情况。
J Clin Lab Anal. 1997;11(2):94-103. doi: 10.1002/(SICI)1098-2825(1997)11:2<94::AID-JCLA5>3.0.CO;2-K.
5
Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.晚期卵巢癌患者二次剖腹探查术中的手术细胞减灭术。
Anticancer Res. 2000 May-Jun;20(3B):1959-64.
6
Resection guided by antibodies (REGAJ) a reappraisal after 10 years.抗体引导下的切除术（REGAJ）：10年后的重新评估
Int J Biol Markers. 1998 Oct-Dec;13(4):221-3.
7
Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Anticancer Res. 1988 Jul-Aug;8(4):761-4.
8
Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
Obstet Gynecol. 1989 Sep;74(3 Pt 1):379-83.
9
[Application of monoclonal antibody OC 125 in gynecological oncology].单克隆抗体OC 125在妇科肿瘤学中的应用
Zhonghua Zhong Liu Za Zhi. 1988 Mar;10(2):132-6.
10
[REGAJ diagnosis of recurrence of ovarian cancer].[REGAJ对卵巢癌复发的诊断]
Gynakol Rundsch. 1989;29 Suppl 2:360-3.
引用本文的文献
1
A comprehensive overview of radioguided surgery using gamma detection probe technology.使用伽马探测探头技术的放射引导手术综述
World J Surg Oncol. 2009 Jan 27;7:11. doi: 10.1186/1477-7819-7-11.
2
Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.卵巢癌患者中，在抗体引导下切除肿瘤（REGAJ）后放射性标记的抗CA125单克隆抗体OC125 - F(ab)2片段的分布情况。
J Clin Lab Anal. 1997;11(2):94-103. doi: 10.1002/(SICI)1098-2825(1997)11:2<94::AID-JCLA5>3.0.CO;2-K.
3
Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.在体外灌注模型中使用抗γ-谷氨酰转移酶单克隆抗体对肾肿瘤进行免疫闪烁显像定位。
Cancer Immunol Immunother. 1992;35(4):283-8. doi: 10.1007/BF01789336.
本文引用的文献
1
The changing role of "second-look" laparotomy in the management of epithelial carcinoma of the ovary.“二次探查”剖腹术在卵巢上皮癌治疗中不断变化的作用。
Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 1):612-6. doi: 10.1016/s0002-9378(16)32428-0.
2
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.单克隆抗体OC125识别的一种体腔上皮相关抗原的组织分布
Int J Gynecol Pathol. 1983;2(3):275-85. doi: 10.1097/00004347-198303000-00005.
3
Second-look laparotomy in managing epithelial ovarian carcinoma.二次剖腹探查术在上皮性卵巢癌治疗中的应用
Cancer. 1986 Apr 15;57(8):1627-31. doi: 10.1002/1097-0142(19860415)57:8<1627::aid-cncr2820570831>3.0.co;2-d.
4
Immunoscintigraphy of recurrences of gynecologic carcinomas.
J Nucl Med. 1987 Dec;28(12):1807-19.
5
Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
Am J Obstet Gynecol. 1988 Nov;159(5):1094-8. doi: 10.1016/0002-9378(88)90420-6.
6
Distribution and pharmacokinetics of radiolabeled monoclonal antibody OC 125 after intravenous and intraperitoneal administration in gynecologic tumors.
Am J Obstet Gynecol. 1988 Oct;159(4):843-8. doi: 10.1016/s0002-9378(88)80150-9.
7
Is routine second-look laparotomy for ovarian cancer justified?卵巢癌常规二次剖腹探查术是否合理？
Gynecol Oncol. 1988 Oct;31(2):249-55. doi: 10.1016/s0090-8258(88)80001-5.
8
Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.血清CA-125作为卵巢癌二次探查手术时机及二线治疗的指导指标。
Arch Gynecol Obstet. 1988;243(2):91-9. doi: 10.1007/BF00932974.
Zotero 插件